Risk factors

What each company says could go wrong in its 10-K, and what changed since last year: the risks added, dropped and rewritten.

7,677 annual reports · 4,010 companies

Readings are automated and can be wrong; check the filing for the exact wording.

Older filings

Page 619 of 640 · 7,677 filings

  • Heico (HEI) FY2024 10-K risk factors
    20 risks

    HEICO's risk profile is dominated by aerospace industry cyclicality, defense spending exposure, and FAA regulatory compliance. The company faces significant execution risks from its aggressive acquisition strategy and high concentration of intangible assets. Operational continuity depends heavily on specialized component supply chains, foreign market sales, and protection against product liability claims.

    Filed Dec 19, 2024
  • Hewlett Packard Enterprise (HPE) FY2024 10-K risk factors
    33 risks

    The company's primary risks center on executing its edge-to-cloud as-a-Service strategy and integrating the pending acquisition of Juniper Networks.

    Filed Dec 19, 2024
  • GEE Group (JOB) FY2024 10-K risk factors
    41 risks

    GEE Group faces heavy credit, cash flow, and staffing volatility risks without prior year comparisons.

    Filed Dec 19, 2024
  • LIVE Ventures (LIVE) FY2024 10-K risk factors
    48 risks

    The company faces substantial risks from its $151.2 million in debt and floating interest rates. Ongoing SEC investigations and labor or supply chain disruptions threaten operations across subsidiaries like Vintage Stock, Marquis, and Precision Marshall.

    Filed Dec 19, 2024
  • Latch (LTCH) FY2022 10-K risk factors
    70 risks

    Latch faces an ongoing SEC investigation and has incurred high professional expenses from a financial statement review and restatement. The company relies heavily on limited third-party suppliers and channel partners while developing new platforms like HelloTech and James. Restructurings, workforce reductions, and historical net operating losses create uncertainty regarding future profitability and capital needs.

    Filed Dec 19, 2024
  • Optex Systems Holdings (OPXS) FY2024 10-K risk factors
    24 risks

    Reliance on a small group of U.S. government agencies and defense contractors for nearly half of total revenue. Severe supply chain concentration risks requiring up to ten months to re-qualify alternative suppliers. Operational vulnerability to past ransomware attacks and general information technology disruptions.

    Filed Dec 19, 2024
  • Photronics (PLAB) FY2024 10-K risk factors
    33 risks

    Volatility in the microelectronics and semiconductor industries heavily impacts photomask demand.

    Filed Dec 19, 2024
  • Synopsys (SNPS) FY2024 10-K risk factors
    31 risks

    Synopsys faces major execution and leverage risks related to the pending Ansys Merger, alongside high customer concentration in the semiconductor industry.

    Filed Dec 19, 2024
  • Hovnanian Enterprises (HOV) FY2024 10-K risk factors
    33 risks

    This company faces heavy leverage with $881.6 million in debt and relies on operating cash flow that dropped to $23.6 million in fiscal 2024. It is exposed to geographic concentration in states like Texas, where Hurricane Beryl caused disruptions, and relies on subcontractors and regional land availability. Significant federal net operating loss carryforwards of $398.8 million remain subject to ownership change limits under Section 382.

    Filed Dec 18, 2024
  • Nordson (NDSN) FY2024 10-K risk factors
    25 risks

    International markets generate sixty seven percent of revenue exposing the company to currency and geopolitical risks. Acquisitions like Atrion drive growth but entail integration risks and debt covenants. Regulatory compliance spans cybersecurity data privacy environmental and anti-corruption laws globally.

    Filed Dec 18, 2024
  • Toro (TTC) FY2024 10-K risk factors
    34 risks

    Supply chain disruptions and tariffs on Chinese engines threaten component availability and margins.

    Filed Dec 18, 2024
  • cbdMD (YCBD) FY2024 10-K risk factors
    34 risks

    cbdMD faces severe going concern doubts after consecutive revenue declines and operating losses totaling $25.8 million over two years. The company struggles with NYSE American continued listing compliance and suspended dividends on its Series A Convertible Preferred Stock. Complex federal and state regulatory frameworks regarding hemp, CBD, and THC create ongoing legal, supply chain, and advertising uncertainties.

    Filed Dec 18, 2024

Companies covered

4,010 companies

371 more under A